No article text was recorded for this version.
treatment response heterogeneity
Version 1 of 117 papers18 conceptsfrozen 2026-10-04
Papers in this version
- Blog: A novel risk score for disease control prediction of chronic rhinosinusitis
- Blog: Performance of AI-based machine learning models for overall survival prediction in advanced hepatocellular carcinoma patients receiving immunoradiotherapy
- Blog: Whole slide image-based weakly supervised deep learning for predicting major pathological response in non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a multicenter, retrospective, cohort study
- Blog: 1294 External validation of machine learning models to predict efficacy and toxicity of immune checkpoint inhibitors using real-world pan cancer cohorts
- Blog: Multiparametric MRI and Whole Slide Image-Based Pretreatment Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Multicenter Radiopathomic Study
- Blog: Deep Learning-Based Multimodal Prediction of NAC Response in LARC by Integrating MRI and Proteomics
- Blog: Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma
- Blog: Development and validation of nomogram for predicting pathological complete response to neoadjuvant chemotherapy and immunotherapy for locally advanced gastric cancer: a multicenter real-world study in China
- Blog: The systemic oxidative stress index predicts clinical outcomes of esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy
- Blog: Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy
- Blog: Antitumor Activity of Ruditapes philippinarum Polysaccharides Through Mitochondrial Apoptosis in Cellular and Zebrafish Models
- Blog: Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
- Blog: Attention mechanism based multi-sequence MRI fusion improves prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
- Blog: Cancer stem cell-related factors are associated with the efficacy of pre-operative chemoradiotherapy for locally advanced rectal cancer
- Blog: Prognostic model of immune-related genes for patients with hepatocellular carcinoma
- Blog: Characterization and proteomic analysis of plasma-derived small extracellular vesicles in locally advanced rectal cancer patients
- Blog: Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
History & citation
Current · Permanent link
- This direction split from Predictive Modeling for Personalized Treatment Response (88% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_treatment_response_heterogeneity_20bffca6,
title = {treatment response heterogeneity},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/treatment-response-heterogeneity/rdr_20bffca67443440184baafb939701ced},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_treatment_response_heterogeneity_20bffca6_v1,
title = {treatment response heterogeneity},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/treatment-response-heterogeneity/rdr_20bffca67443440184baafb939701ced/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}